2020 Q4 Form 10-K Financial Statement
#000117184321001963 Filed on March 22, 2021
Income Statement
| Concept | 2020 Q4 | 2019 Q4 | 2019 |
|---|---|---|---|
| Revenue | $2.370M | $3.820M | $13.60K |
| YoY Change | -37.96% | 37.41% | -99.9% |
| Cost Of Revenue | $1.240M | $1.510M | $5.657M |
| YoY Change | -17.88% | 21.77% | 5.87% |
| Gross Profit | $1.130M | $2.310M | -$5.644M |
| YoY Change | -51.08% | 50.0% | -169.66% |
| Gross Profit Margin | 47.68% | 60.47% | -41500.99% |
| Selling, General & Admin | |||
| YoY Change | |||
| % of Gross Profit | |||
| Research & Development | $120.0K | $100.0K | $397.4K |
| YoY Change | 20.0% | -9.09% | -0.53% |
| % of Gross Profit | 10.62% | 4.33% | |
| Depreciation & Amortization | $50.00K | $50.00K | $175.8K |
| YoY Change | 0.0% | 0.0% | -8.4% |
| % of Gross Profit | 4.42% | 2.16% | |
| Operating Expenses | $620.0K | $660.0K | $397.4K |
| YoY Change | -6.06% | 1.54% | -81.28% |
| Operating Profit | $510.0K | $1.650M | $5.396M |
| YoY Change | -69.09% | 85.39% | -3.3% |
| Interest Expense | $250.0K | $120.0K | $630.0K |
| YoY Change | 108.33% | -163.16% | -730.0% |
| % of Operating Profit | 49.02% | 7.27% | 11.68% |
| Other Income/Expense, Net | $634.4K | ||
| YoY Change | -656.55% | ||
| Pretax Income | $760.0K | $1.780M | $6.030M |
| YoY Change | -57.3% | 157.97% | 10.33% |
| Income Tax | $150.0K | $390.0K | $1.269M |
| % Of Pretax Income | 19.74% | 21.91% | 21.04% |
| Net Earnings | $610.0K | $1.390M | $4.762M |
| YoY Change | -56.12% | 139.66% | 9.41% |
| Net Earnings / Revenue | 25.74% | 36.39% | 35014.94% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | $132.9K | $302.8K | $1.037M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 4.594M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2020 Q4 | 2019 Q4 | 2019 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $8.180M | $7.920M | $7.920M |
| YoY Change | 3.28% | -3.06% | -3.06% |
| Cash & Equivalents | $591.4K | $1.048M | $1.050M |
| Short-Term Investments | $7.590M | $6.870M | $6.870M |
| Other Short-Term Assets | $260.0K | $340.0K | $340.0K |
| YoY Change | -23.53% | -5.56% | -5.56% |
| Inventory | $1.416M | $1.217M | $1.220M |
| Prepaid Expenses | |||
| Receivables | $1.388M | $2.098M | $2.100M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $11.25M | $11.57M | $11.57M |
| YoY Change | -2.77% | -1.03% | -1.03% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $673.7K | $780.7K | $780.0K |
| YoY Change | -13.71% | -5.7% | -6.02% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $14.82K | $10.00K | |
| YoY Change | -50.0% | -66.67% | |
| Total Long-Term Assets | $673.7K | $795.5K | $790.0K |
| YoY Change | -15.32% | -7.23% | -7.06% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $11.25M | $11.57M | $11.57M |
| Total Long-Term Assets | $673.7K | $795.5K | $790.0K |
| Total Assets | $11.92M | $12.36M | $12.36M |
| YoY Change | -3.58% | -1.45% | -1.44% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $31.80K | $71.39K | $70.00K |
| YoY Change | -55.45% | -61.78% | -63.16% |
| Accrued Expenses | $1.363M | $1.129M | $1.130M |
| YoY Change | 20.75% | 8.5% | 8.65% |
| Deferred Revenue | $0.00 | ||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $1.414M | $1.343M | $1.340M |
| YoY Change | 5.3% | -1.69% | -2.19% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.414M | $1.343M | $1.340M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $1.570M | $1.730M | $1.730M |
| YoY Change | -9.25% | 6.79% | 6.79% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $9.895M | $10.17M | |
| YoY Change | -2.74% | -2.79% | |
| Common Stock | $459.4K | $459.4K | |
| YoY Change | 0.0% | 0.0% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $10.35M | $10.63M | $10.63M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $11.92M | $12.36M | $12.36M |
| YoY Change | -3.58% | -1.45% | -1.44% |
Cashflow Statement
| Concept | 2020 Q4 | 2019 Q4 | 2019 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $610.0K | $1.390M | $4.762M |
| YoY Change | -56.12% | 139.66% | 9.41% |
| Depreciation, Depletion And Amortization | $50.00K | $50.00K | $175.8K |
| YoY Change | 0.0% | 0.0% | -8.4% |
| Cash From Operating Activities | $670.0K | $850.0K | $4.476M |
| YoY Change | -21.18% | -18.27% | -9.58% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$10.00K | -$10.00K | $113.8K |
| YoY Change | 0.0% | 51.71% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $700.0K | $940.0K | $1.190M |
| YoY Change | -25.53% | -28.79% | -617.39% |
| Cash From Investing Activities | $690.0K | $930.0K | $1.072M |
| YoY Change | -25.81% | -29.01% | -447.19% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | $5.050M | ||
| YoY Change | 4.85% | ||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -1.650M | -2.530M | -5.050M |
| YoY Change | -34.78% | 0.0% | 4.85% |
| NET CHANGE | |||
| Cash From Operating Activities | 670.0K | 850.0K | 4.476M |
| Cash From Investing Activities | 690.0K | 930.0K | 1.072M |
| Cash From Financing Activities | -1.650M | -2.530M | -5.050M |
| Net Change In Cash | -290.0K | -750.0K | 498.2K |
| YoY Change | -61.33% | 316.67% | -385.35% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $670.0K | $850.0K | $4.476M |
| Capital Expenditures | -$10.00K | -$10.00K | $113.8K |
| Free Cash Flow | $680.0K | $860.0K | $4.362M |
| YoY Change | -20.93% | -17.31% | -10.52% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
|
6446276 | |
| CY2020Q4 | ug |
Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
|
63432 | |
| CY2019Q4 | ug |
Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
|
64324 | |
| CY2020Q4 | ug |
Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
|
325792 | |
| CY2019Q4 | ug |
Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
|
309190 | |
| CY2020Q4 | ug |
Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
|
302715 | |
| CY2019Q4 | ug |
Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
|
231392 | |
| CY2020Q4 | ug |
Convertible Common Stock Shares Issuable Upon Conversion
ConvertibleCommonStockSharesIssuableUponConversion
|
1369 | |
| CY2020Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
|
7287151 | |
| CY2020Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
|
7591381 | |
| CY2019Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
|
6867516 | |
| CY2020Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
|
304230 | |
| CY2019Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
|
421240 | |
| CY2020Q4 | ug |
Deferred Tax Assets Accounts Payable
DeferredTaxAssetsAccountsPayable
|
6678 | |
| CY2019Q4 | ug |
Deferred Tax Assets Accounts Payable
DeferredTaxAssetsAccountsPayable
|
14991 | |
| CY2020Q4 | ug |
Deferred Tax Liabilities Accounts Receivable
DeferredTaxLiabilitiesAccountsReceivable
|
294360 | |
| CY2019Q4 | ug |
Deferred Tax Liabilities Accounts Receivable
DeferredTaxLiabilitiesAccountsReceivable
|
445113 | |
| CY2020Q4 | ug |
Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
|
304230 | |
| CY2019Q4 | ug |
Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
|
421240 | |
| CY2019 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
15964917 | |
| CY2020 | us-gaap |
Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
|
Lesser of useful life or 20 years | |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7433920 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7390525 | |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
673665 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
780707 | |
| CY2019 | ug |
Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
|
||
| CY2020 | ug |
Number Of Vendors
NumberOfVendors
|
6 | |
| CY2020 | ug |
Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
|
-124657 | |
| CY2020Q4 | ug |
Payments For Accrued Dividends On Unconverted Shares
PaymentsForAccruedDividendsOnUnconvertedShares
|
124041 | |
| CY2020Q3 | ug |
Payments For Accrued Dividends On Unconverted Shares
PaymentsForAccruedDividendsOnUnconvertedShares
|
124041 | |
| CY2020 | ug |
Reserve For Inventories
ReserveForInventories
|
||
| CY2019 | ug |
Reserve For Inventories
ReserveForInventories
|
15000 | |
| CY2020 | ug |
Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
|
12436332 | |
| CY2019 | ug |
Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
|
14753831 | |
| CY2020 | ug |
Sales Returns And Allowances
SalesReturnsAndAllowances
|
1450251 | |
| CY2019 | ug |
Sales Returns And Allowances
SalesReturnsAndAllowances
|
1154747 | |
| CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
31800 | |
| CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
71385 | |
| CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1387698 | |
| CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2098411 | |
| CY2020Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
210000 | |
| CY2019Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
216000 | |
| CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1363457 | |
| CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1129126 | |
| CY2020Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
149346 | |
| CY2019Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
46100 | |
| CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
50500 | |
| CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
48500 | |
| CY2020Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
245521 | |
| CY2019Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
175433 | |
| CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6760255 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6609818 | |
| CY2020 | us-gaap |
Advertising Expense
AdvertisingExpense
|
27000 | |
| CY2019 | us-gaap |
Advertising Expense
AdvertisingExpense
|
28000 | |
| CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
14017 | |
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
21178 | |
| CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
14017 | |
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
21178 | |
| CY2020Q4 | us-gaap |
Assets
Assets
|
11920276 | |
| CY2019Q4 | us-gaap |
Assets
Assets
|
12362812 | |
| CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11246611 | |
| CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11567281 | |
| CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
||
| CY2020Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
2848585 | |
| CY2019Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
2839289 | |
| CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
591444 | |
| CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1048311 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1048311 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
550135 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
591444 | |
| CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-456867 | |
| CY2019 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
498176 | |
| CY2020Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
653000 | |
| CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2020Q2 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.42 | |
| CY2019Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.55 | |
| CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.10 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.10 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4594319 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4594319 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4594319 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4594319 | |
| CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
459432 | |
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
459432 | |
| CY2020 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risk</div></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer's prior payment history to determine how much credit to allow or whether any credit should be given at all. It is the Company's policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable. As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company's sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </div> <!-- Field: Page; Sequence: 44; Value: 1 --> <!-- Field: /Page --> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div><div style="display: inline; font-style: italic; font: inherit;">four</div> of the Company's distributors and marketing partners accounted for approximately <div style="display: inline; font-style: italic; font: inherit;">72%</div> of the Company's gross sales during the year and approximately <div style="display: inline; font-style: italic; font: inherit;">67%</div> of its outstanding accounts receivable at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>For the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019, </div>the same <div style="display: inline; font-style: italic; font: inherit;">four</div> distributors and marketing partners accounted for a total of approximately <div style="display: inline; font-style: italic; font: inherit;">70%</div> of the Company's gross sales during the year and <div style="display: inline; font-style: italic; font: inherit;">70%</div> of its outstanding accounts receivable at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> | |
| CY2020 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4872335 | |
| CY2019 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
5657353 | |
| CY2020 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
7349911 | |
| CY2019 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
8203119 | |
| CY2020 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
1091148 | |
| CY2019 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
1135209 | |
| CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
1091193 | |
| CY2019 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
1135387 | |
| CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
45 | |
| CY2019 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
178 | |
| CY2020 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
298585 | |
| CY2019 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
431076 | |
| CY2020 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
415595 | |
| CY2019 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
262399 | |
| CY2020 | us-gaap |
Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
|
-117010 | |
| CY2019 | us-gaap |
Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
|
168677 | |
| CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-235171 | |
| CY2019 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
133272 | |
| CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-235171 | |
| CY2019 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
133272 | |
| CY2020Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
452801 | |
| CY2019Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
649276 | |
| CY2020Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
151684 | |
| CY2019Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
386855 | |
| CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
||
| CY2019 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
||
| CY2020Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
7350 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
7350 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
301117 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
262421 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
284145 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
235633 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
2944 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
4447 | |
| CY2020Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
151684 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
386855 | |
| CY2020Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
33829 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
42319 | |
| CY2020Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
60724 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
73384 | |
| CY2020Q4 | us-gaap |
Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
|
63888 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
|
88460 | |
| CY2020 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
165261 | |
| CY2019 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
175810 | |
| CY2020 | us-gaap |
Dividends
Dividends
|
3583569 | |
| CY2019 | us-gaap |
Dividends
Dividends
|
5053751 | |
| CY2020Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
19028 | |
| CY2019Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
142548 | |
| CY2020Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
1138 | |
| CY2019Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
3829 | |
| CY2020 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.72 | |
| CY2019 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
1.04 | |
| CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.206 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.211 | |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
|
0.001 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
|
||
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
||
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
||
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.002 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.001 | |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.001 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.002 | |
| CY2020Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
7591381 | |
| CY2019Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
3385891 | |
| CY2020Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
7287151 | |
| CY2019Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
2964651 | |
| CY2020Q4 | us-gaap |
Fixtures And Equipment Gross
FixturesAndEquipmentGross
|
4516335 | |
| CY2019Q4 | us-gaap |
Fixtures And Equipment Gross
FixturesAndEquipmentGross
|
4482236 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
3481625 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
3481625 | |
| CY2020 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
| CY2019 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
4161000 | |
| CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
6030370 | |
| CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
856022 | |
| CY2019 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1268659 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
|
3000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
|
2000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
874000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1266000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
||
| CY2019 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
1000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
|
10000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
|
8000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-5000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
12000 | |
| CY2020 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1025000 | |
| CY2019 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1100000 | |
| CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1025000 | |
| CY2019 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1100000 | |
| CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-39585 | |
| CY2019 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-115412 | |
| CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-717874 | |
| CY2019 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
430127 | |
| CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
234331 | |
| CY2019 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
88491 | |
| CY2020 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
198496 | |
| CY2019 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-249874 | |
| CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-9258 | |
| CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
11102 | |
| CY2020 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
-66193 | |
| CY2019 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
-35387 | |
| CY2020Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
941100 | |
| CY2019Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
815768 | |
| CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
1415773 | |
| CY2019Q4 | us-gaap |
Inventory Net
InventoryNet
|
1217277 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1071987 | |
| CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
3594240 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
4476111 | |
| CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3304978 | |
| CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-468676 | |
| CY2020 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-7161 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-5049922 | |
| CY2020Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
415415 | |
| CY2019Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
320507 | |
| CY2020Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
35000 | |
| CY2019Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
35000 | |
| CY2020Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
59258 | |
| CY2019Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
81002 | |
| CY2020 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
226245 | |
| CY2019 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
203329 | |
| CY2020Q4 | us-gaap |
Land
Land
|
69000 | |
| CY2019Q4 | us-gaap |
Land
Land
|
69000 | |
| CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11920276 | |
| CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12362812 | |
| CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1414285 | |
| CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1343059 | |
| CY2020Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
7591381 | |
| CY2019Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
6867516 | |
| CY2020 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
298585 | |
| CY2019 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
431076 | |
| CY2020 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
298585 | |
| CY2019 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
431076 | |
| CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3582431 | |
| CY2019 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4761711 | |
| CY2020 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
524830 | |
| CY2019 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
634405 | |
| CY2020 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2020 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
2026368 | |
| CY2019 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
2148375 | |
| CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
3636170 | |
| CY2019 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5395965 | |
| CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
16153 | |
| CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
38187 | |
| CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
||
| CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
14824 | |
| CY2020 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
3582431 | |
| CY2019 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
5049922 | |
| CY2020 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
3582431 | |
| CY2019 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
5049922 | |
| CY2020 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
6796409 | |
| CY2019 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
14779161 | |
| CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
43395 | |
| CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
113769 | |
| CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
161208 | |
| CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
170466 | |
| CY2020Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
99107 | |
| CY2019Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
165300 | |
| CY2020 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
6371128 | |
| CY2019 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
4283 | |
| CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
451208 | |
| CY2019 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
397391 | |
| CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
9894875 | |
| CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
10173466 | |
| CY2020 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
10986081 | |
| CY2019 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
13599.084 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10354307 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10632898 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10924938 | |
| CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2020Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
| CY2019Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
| CY2020 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In preparing financial statements in conformity with a Generally Accepted Accounting Principles in the United States of America (“US GAAP”), management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, reserve for inventory obsolescence, accrued distribution fees, outdated material returns, possible impairment of marketable securities and the allocation of overhead.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> | |
| CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4594319 | |
| CY2019 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4594319 |
